GlassScriptPhysician profile
Heather S Dolman
NPI 1467460170
$2,536.50
in general payments reported to CMS, 2019-2025
12 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2022: $912 · 2023: $359 · 2024: $762 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,303 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.00 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $659.53 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $611.88 | 2022 | |
| Aroa Biosurgery Incorporated | $377.04 | 2022-2024 | |
| Becton, Dickinson and Company | $156.04 | 2019 | |
| Prytime Medical Devices, INC. | $145.56 | 2019 | |
| Smith+Nephew, INC. | $121.66 | 2022 | |
| Solventum Corporation | $110.51 | 2024 | Prevena |
| Abbvie INC. | $108.07 | 2025 | |
| Acera Surgical, INC. | $93.95 | 2025 | Restrata Wound Matrix |
| Kci USA, INC. | $76.49 | 2022 | |
| Tela Bio, INC. | $55.77 | 2024 | Ovitex 2s |
| Csl Behring | $20.00 | 2024 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Dolman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.